Interesting grey area indeed!
Decisive factors do not only include WACC (cost of recapitalisation, cost of debt), also
cost/disadvantages of dilution,
impact of the pre-sale on future revenues (depending on the size of the reserve and development of the helium spot price),
debt/equity ratio,
regulatory advantages/disadvantages/risks,
the marketing side/public awareness generated and its benefits for the company…
Independent of the fact whether Renergen is a buy, this is a very interesting case to watch and see whether/how it influences other companies’ funding decisions.
RENERGEN ROAD TO REVENUE, page-208
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RLT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
71.5¢ |
Change
0.005(0.70%) |
Mkt cap ! $21.68M | |||
| Open | High | Low | Value | Volume |
| 71.5¢ | 72.5¢ | 71.0¢ | $30.69K | 42.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2500 | 71.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 73.0¢ | 293 | 1 |
View Market Depth
| Last trade - 15.48pm 12/07/2024 (20 minute delay) ? |
| RLT (ASX) Chart |